Log in

Start free trial
Home 5 Articles 5 FDA Issues First Approval for SARS-CoV-2 Breathalyzer Test

FDA Issues First Approval for SARS-CoV-2 Breathalyzer Test

by | May 2, 2022 | Articles, FDA-lir, Laboratory Industry Report

InspectIR COVID-19 device detects the virus from breath samples in less than three minutes, offering a new screening option.

Blue illustration of coronavirus particles in the air

InspectIR COVID-19 device detects the virus from breath samples in less than three minutes, offering a new screening option.

This content is for Paid Members only.
Login Register